Filing Flows › Nutra Pharma (NPHC) › Q2 2026 › vs Q2 2025
Nutra Pharma (NPHC) Q2 2026 vs Q2 2025 (year over year)
Nutra Pharma's revenue fell $50K (-59%) from $85K in Q2 2025 to $34K in Q2 2026.
Nutra Pharma, Q2 2026: revenue $34K (-59% year over year), net loss $3.9M, operating cash flow −$251K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $34K | $85K | −$50K | -59% |
| Net loss | $3.9M | −$370K | $4.3M | — |
| Costs & expenses | $4.0M | $745K | $3.2M | +435% |
| Operating costs | $470K | $375K | $95K | +25% |
| Interest & other, net | $3.5M | −$660K | $4.2M | — |
| Cost of revenue | $2K | $21K | −$19K | -91% |
| Operating expenses | $468K | $354K | $114K | +32% |
| Operating cash sources | $3.9M | −$370K | $4.3M | — |
| Depreciation | $2K | $3K | −$1K | -25% |
| Share-based compensation | $4K | $2K | $2K | +115% |
| Working capital & other | $3.7M | −$663K | $4.4M | — |
| Cash used in operations | $251K | $288K | −$37K | -13% |
| Net loss absorbed | $3.9M | −$370K | $4.3M | — |
Questions
How much did Nutra Pharma's revenue grow year over year in Q2 2026?
Nutra Pharma's revenue fell $50K (-59%) from $85K in Q2 2025 to $34K in Q2 2026.